Literature DB >> 8446617

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

W J Strittmatter1, A M Saunders, D Schmechel, M Pericak-Vance, J Enghild, G S Salvesen, A D Roses.   

Abstract

Apolipoprotein E is immunochemically localized to the senile plaques, vascular amyloid, and neurofibrillary tangles of Alzheimer disease. In vitro, apolipoprotein E in cerebrospinal fluid binds to synthetic beta A4 peptide (the primary constituent of the senile plaque) with high avidity. Amino acids 12-28 of the beta A4 peptide are required. The gene for apolipoprotein E is located on chromosome 19q13.2, within the region previously associated with linkage of late-onset familial Alzheimer disease. Analysis of apolipoprotein E alleles in Alzheimer disease and controls demonstrated that there was a highly significant association of apolipoprotein E type 4 allele (APOE-epsilon 4) and late-onset familial Alzheimer disease. The allele frequency of the APOE-epsilon 4 in 30 random affected patients, each from a different Alzheimer disease family, was 0.50 +/- 0.06; the allele frequency of APOE-epsilon 4 in 91 age-matched unrelated controls was 0.16 +/- 0.03 (Z = 2.44, P = 0.014). A functional role of the apolipoprotein E-E4 isoform in the pathogenesis of late-onset familial Alzheimer disease is suggested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446617      PMCID: PMC46003          DOI: 10.1073/pnas.90.5.1977

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome.

Authors:  J Dausset; H Cann; D Cohen; M Lathrop; J M Lalouel; R White
Journal:  Genomics       Date:  1990-03       Impact factor: 5.736

2.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins.

Authors:  R E Pitas; J K Boyles; S H Lee; D Foss; R W Mahley
Journal:  Biochim Biophys Acta       Date:  1987-01-13

3.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

Authors:  R E Pitas; J K Boyles; S H Lee; D Hui; K H Weisgraber
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

4.  Expression of apolipoprotein E during nerve degeneration and regeneration.

Authors:  M J Ignatius; P J Gebicke-Härter; J H Skene; J W Schilling; K H Weisgraber; R W Mahley; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  Apolipoprotein E polymorphism and coronary artery disease.

Authors:  H J Menzel; R G Kladetzky; G Assmann
Journal:  Arteriosclerosis       Date:  1983 Jul-Aug

6.  Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type.

Authors:  G D Schellenberg; S S Deeb; M Boehnke; E M Bryant; G M Martin; T H Lampe; T D Bird
Journal:  J Neurogenet       Date:  1987-04       Impact factor: 1.250

7.  Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells.

Authors:  G J Snipes; C B McGuire; J J Norden; J A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

Review 8.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

9.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.

Authors:  J K Boyles; C D Zoellner; L J Anderson; L M Kosik; R E Pitas; K H Weisgraber; D Y Hui; R W Mahley; P J Gebicke-Haerter; M J Ignatius
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

10.  Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets.

Authors:  N A Elshourbagy; W S Liao; R W Mahley; J M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

View more
  1045 in total

Review 1.  Microglia and the immune pathology of Alzheimer disease.

Authors:  D Giulian
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

2.  Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

Authors:  M Buttini; M Orth; S Bellosta; H Akeefe; R E Pitas; T Wyss-Coray; L Mucke; R W Mahley
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

3.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

4.  Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.

Authors:  D Fallin; A Cohen; L Essioux; I Chumakov; M Blumenfeld; D Cohen; N J Schork
Journal:  Genome Res       Date:  2001-01       Impact factor: 9.043

5.  Sandwich ELISA for the measurement of Apo-E4 levels in serum and the estimation of the allelic status of Apo-E4 isoforms.

Authors:  Y Uchida; S Ito; N Nukina
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

6.  Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

Authors:  M Tolar; J N Keller; S Chan; M P Mattson; M A Marques; K A Crutcher
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

7.  A microsphere-based assay for multiplexed single nucleotide polymorphism analysis using single base chain extension.

Authors:  J Chen; M A Iannone; M S Li; J D Taylor; P Rivers; A J Nelsen; K A Slentz-Kesler; A Roses; M P Weiner
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

8.  Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.

Authors:  S I Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 9.  Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease.

Authors:  W G Wood; F Schroeder; N A Avdulov; S V Chochina; U Igbavboa
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

10.  Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice.

Authors:  X Bi; A P Yong; J Zhou; C E Ribak; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.